US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% META $728.08 ▲+0.00% NVDA $233.95 ▲+0.00% TSLA $370.59 ▲+0.00% AMD $633.91 ▲+0.00% JNJ $256.03 ▲+0.00% SPCX $158.96 ▲+0.00%
FinancialContent

Articles published by Microbot Medical Inc.

< Previous 1 2 3 4 Next >
News headline image
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Added to the Russell Microcap® Index
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Closes $13 Million Registered Direct Offering
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Announces Late-Breaking Abstract Acceptance at the Society of Interventional Radiology Annual Meeting
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical® Strengthens Its Commercial Capabilities with the Addition of David J. Wilson to the Board of Directors
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Closes $8.6 Million Registered Direct Offering
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
News headline image
Microbot Medical Announces $8.6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
From Microbot Medical Inc.
Via GlobeNewswire
Tickers MBOT
< Previous 1 2 3 4 Next >